GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-CoV-2 NSP3 Macrodomain in complex with ASAP-0000605-001

Analyse Crystal structure of SARS-CoV-2 NSP3 Macrodomain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7GZF
Type
protein
Length
333 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.18
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
Non-structural protein 3
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1
Ligands
A1AKI
Pockets
3 · best druggability 0.67

Structure

x-ray diffraction · resolution 1.18 · 2 distinct chains · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein16441% helix, 20% strandP0DTD1
BNon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein16942% helix, 19% strandP0DTD1

Ligands and binding sites

  • A1AKI · (3R)-3-(4-bromophenyl)-3-[(1-methyl-1H-pyrazolo[3,4-b]pyridine-4-carbonyl)amino]propanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14660.670.7937empty
21730.530.7932A1AKI
31550.520.7923empty

Interfaces

1 interface between chains.

  • A–B · 504 Ų buried · 19 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.